Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

Nature Clinical Practice Oncology

Volumn 2, Issue 6, 2005, Pages 315-324

  Haura, Eric B ^a,b   Turkson, James ^a,b   Jove, Richard ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Apoptosis; Bcl 2 family; Cancer; STAT proteins; Tyrosine kinase inhibitor

Indexed keywords

6 (2,6 DICHLOROPHENYL) 2 (4 FLUORO 3 METHYLANILINO) 8 METHYL 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CYTOKINE; CYTOPLASM PROTEIN; DIMER; GEFITINIB; IMATINIB; JANUS KINASE; JSI 124; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NEW DRUG; OLIGODEOXYNUCLEOTIDE; PEPTIDE DERIVATIVE; PEPTIDE LIBRARY; PLATINUM COMPLEX; PROTEIN INHIBITOR; PROTEIN SH2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL CYCLE; DRUG MECHANISM; DRUG TARGETING; GENETIC TRANSCRIPTION; IMMUNE SYSTEM; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS;

EID: 21344435775     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0195     Document Type: Review

References (70)

1. Darnell JE Jr (1997) STATs and gene regulation. Science 277: 1630-1635
2. Zhong Z et al. (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98
3. Yu CL et al. (1995) Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81-83
4. Yu H and Jove R (2004) The STATs of cancer - new molecular targets come of age. Nat Rev Cancer 4: 97-105
5. Bowman T et al. (2000) STATs in oncogenesis. Oncogene 19: 2474-2488
6. Wen Z et al. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250
7. Bild AH et al. (2002) Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J 21: 3255-3263
8. Zhang X et al. (1999) Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell Biol 19: 7138-7146
9. Starr R et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921
10. Chung CD et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805
11. Lufei C et al. (2003) GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J 22: 1325-1335
12. Reljic R et al. (2000) Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 192: 1841-1848
13. He B et al. (2003) SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A 100: 14133-14138
14. Shen Y et al. (2001) Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A 98: 1543-1548
15. Catlett-Falcone R et al. (1999) Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10: 105-115
16. Epling-Burnette PK et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107: 351-362
17. Real PJ et al. (2002) Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21: 7611-7618
18. Gritsko TT et al. Persistent activation of Stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res, in press
19. Diaz NM et al. (2005) Activation of Stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated Src and Survivin expression. Clin Cancer Res, in press
20. Niu G et al. (2001) Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 61: 3276-3280
21. Kiuchi N et al. (1999) STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 189: 63-73
22. Sinibaldi D et al. (2000) Induction of p21 WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19: 5419-5427
23. Niu G et al. (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008
24. Wang T et al. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10: 48-54
25. Cheng F et al. (2003) A critical role for Stat3 signaling in immune tolerance. Immunity 19: 425-36
26. Xie TX et al. (2004) Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 23: 3550-3560
27. Dauer DJ et al. (2005) Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408
28. Xi S et al. (2003) Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 63: 6763-6771
29. Kazansky AV et al. (2003) Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Cancer Res 63: 8757-8762
30. Huang M et al. (2002) Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene 21: 8804-8816
31. Horita M et al. (2000) Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J Exp Med 191: 977-984
32. Nieborowska-Skorska M et al. (2002) Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood 99: 4531-4539
33. Li H et al. (2004) Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res 64: 4774-4782
34. Nevalainen MT et al. (2004) Signal transducer and activator of transcription-5 activation and breast cancer prognosis. J Clin Oncol 22: 2053-2060
35. Durbin JE et al. (1996) Targeted disruption of the mouse Stall gene results in compromised innate immunity to viral disease. Cell 84: 443-450
36. Kaplan DH et al. (1998) Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 95: 7556-7561
37. Bromberg JF et al. (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A 93: 7673-7678
38. Chin YE et al. (1996) Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272: 719-722
39. Sun WH et al. (1998) Interferon-alpha resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT1 expression. Blood 91: 570-576
40. Chen B et al. (2000) Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res 60: 3290-3298
41. Ramana CV et al. (2000) Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. EMBO J 19: 263-272
42. Sironi JJ and Ouchi T (2003). STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J. Biol Chem 279: 4066-4074
43. Stephanou A et al. (2000) Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 7: 329-330
44. Thomas M et al. (2004) STAT1: a modulator of chemotherapy-induced apoptosis. Cancer Res 64: 8357-8364
45. Huang S (2002). Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 21: 2504-2512
46. Widschwencter A et al. (2002) Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8: 3065-3074
47. Mora LB et al. (2002) Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 62: 6659-6666
48. Grandis JR et al. (2000) Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A 97: 4227-4232
49. Song L et al. (2003) Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene 22: 4150-4165
50. Garcia R et al. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20: 2499-2513
51. Gao H et al. (2004) Stat3 activation in acute lung injury. J Immunol 172: 7703-7712
52. Hokuto I et al. Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 113: 28-37
53. Sano S et al. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J 18: 4657-6468
54. Kano A et al. (2003) Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med 198: 1517-1525
55. Chan KS et al. (2004) Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 114: 720-728
56. Greten FR et al. (2002) Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 123: 2052-2063
57. Sanchez A et al. (2003) STAT-3 activity in chemically-induced hepatocellular carcinoma. Eur J Cancer 39: 2093-2098
58. Ren S et al. (2002) Loss of Stat5a delays mammary cancer progression in a mouse model. Oncogone 21: 4335-4339
59. Nikitakis NG et al. (2002) The nonsteroical antiinflammatory drug sulindac causes down-regulation of signal transducer and activator of transcription 3 in human oral squamous cell carcinoma cells. Cancer Res 62: 1004-1007
60. Turkson J (2004) STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets 8: 409-422
61. Blaskovich MA et al. (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63: 1270-1279
62. Turkson J et al. (2004) Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent anti-tumor activity. Mol Cancer Ther 3: 1-10
63. Turkson J et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA-binding activity, gene regulation and cell transformation. J Biol Chem 276: 45443-45455
64. Ren Z et al. (2003) Identification of a high-affinity phosphopeptide inhibitor of stat3. Bioorg Med Chem Lett 13: 633-636
65. Nagel-Wolfrum K et al. (2004) The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol Cancer Res 2: 170-182
66. Jing N et al. (2003) Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells. DNA Cell Biol 22: 685-696
67. Leong PL et al. (2003) Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci U S A 100: 4138-4143
68. Konnikova L et al. (2003) Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3: 23
69. Yin N et al. (2004) Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64: 5870-5875
70. Giraud S et al. (2002) Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem 277: 8004-8011